China Shineway Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
China Shineway Pharmaceutical Group has a total shareholder equity of CN¥6.6B and total debt of CN¥300.0M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are CN¥8.9B and CN¥2.3B respectively. China Shineway Pharmaceutical Group's EBIT is CN¥957.6M making its interest coverage ratio -9.7. It has cash and short-term investments of CN¥5.4B.
Key information
4.5%
Debt to equity ratio
CN¥300.00m
Debt
Interest coverage ratio | -9.7x |
Cash | CN¥5.36b |
Equity | CN¥6.64b |
Total liabilities | CN¥2.26b |
Total assets | CN¥8.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CSWY.F's short term assets (CN¥7.4B) exceed its short term liabilities (CN¥2.1B).
Long Term Liabilities: CSWY.F's short term assets (CN¥7.4B) exceed its long term liabilities (CN¥185.9M).
Debt to Equity History and Analysis
Debt Level: CSWY.F has more cash than its total debt.
Reducing Debt: CSWY.F's debt to equity ratio has increased from 0% to 4.5% over the past 5 years.
Debt Coverage: CSWY.F's debt is well covered by operating cash flow (327.4%).
Interest Coverage: CSWY.F earns more interest than it pays, so coverage of interest payments is not a concern.